基于Cas13a的淋病奈瑟菌检测及阿奇霉素耐药鉴定方法的开发与应用
研究开发了基于Cas13a的SHERLOCK检测法,用于检测淋病奈瑟菌porA基因及鉴定阿奇霉素耐药突变A2059G和C2611T。该方法灵敏度达10拷贝/反应(A2059G为100拷贝/反应),与Cobas 4800在43份尿液样本中结果100%一致,并在84株临床分离株中区分出21株携带耐药突变。作者认为该法在临床应用中具有前景。
要点
- SHERLOCK法检测淋病奈瑟菌porA基因灵敏度为10拷贝/反应。
- 鉴定A2059G突变灵敏度为100拷贝/反应。
- 与Cobas 4800比较,18份阳性与25份阴性尿液样本结果100%一致。
核心结论
- 基于Cas13a的SHERLOCK法可快速检测淋病奈瑟菌并同时检测阿奇霉素耐药,作者认为其在临床应用中具有前景。
研究设计与样本
- 开发基于Cas13a的SHERLOCK检测法,用于检测淋病奈瑟菌porA基因及阿奇霉素耐药突变A2059G和C2611T。
- 用纯化双链DNA评估灵敏度,用17株非淋病奈瑟菌菌株评估特异性。
- 用43份尿液样本比较SHERLOCK(porA)与Roche Cobas 4800的性能。
- 用84株临床分离株和18份尿液样本评估阿奇霉素耐药突变A2059G和C2611T的鉴定。
- 测试侧向层析作为该检测法的读出工具,并直接检测27份尿道炎患者的尿道拭子。
主要发现
- SHERLOCK法成功开发,灵敏度为10拷贝/反应,但A2059G为100拷贝/反应,且与其他物种无交叉反应。
- 与Cobas 4800比较,18份阳性与25份阴性尿液样本结果100%一致。
- 84株分离株中区分出21株携带阿奇霉素耐药突变,并经测序和MIC测定验证。
- 27份拭子样本中62.96%(17/27)检测出淋病奈瑟菌,测序未确认突变株。
关键数值与推荐
- SHERLOCK法检测淋病奈瑟菌porA基因的灵敏度为10拷贝/反应。
- 检测A2059G突变的灵敏度为100拷贝/反应。
- 与Cobas 4800比较,18份阳性与25份阴性尿液样本结果100%一致。
- 84株临床分离株中21株携带阿奇霉素耐药突变。
- 27份尿道拭子中62.96%(17/27)检测出淋病奈瑟菌,测序未确认突变株。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gonorrhoea, caused by Neisseria gonorrhoeae, has spread worldwide. Strains resistant to most antibiotics, including ceftriaxone and azithromycin, have emerged to an alarming level. Rapid testing for N. gonorrhoeae and its antimicrobial resistance will therefore contribute to clinical decision making for early diagnosis and rational drug use. METHODS: A Cas13a-based assay (specific high-sensitivity enzymatic reporter unlocking; SHERLOCK) was developed for N. gonorrhoeae detection (porA gene) and azithromycin resistance identification (A2059G, C2611T). Assays were evaluated for sensitivity with purified dsDNA and specificity with 17 non-gonococcal strains. Performance of SHERLOCK (porA) was compared with Roche Cobas 4800 using 43 urine samples. Identification of azithromycin resistance mutations (A2059G, C2611T) was evaluated using a total of 84 clinical isolates and 18 urine samples. Lateral flow was tested for this assay as a readout tool. Moreover, we directly assayed 27 urethral swabs from patients with urethritis to evaluate their status in terms of N. gonorrhoeae infection and azithromycin resistance. RESULTS: The SHERLOCK assay was successfully developed with a sensitivity of 10 copies/reaction, except 100 copies/reaction for A2059G, and no cross-reaction with other species. Comparison of the SHERLOCK assay with the Cobas 4800 revealed 100% concordance within 18 positive and 25 negative urine samples. Of the 84 isolates, 21 strains with azithromycin resistance mutations were distinguished and further verified by sequencing and MIC determination. In addition, 62.96% (17/27) strains from swab samples were detected with no mutant strains confirmed by sequencing. CONCLUSIONS: The SHERLOCK assay for rapid N. gonorrhoeae detection combined with azithromycin resistance testing is a promising method for application in clinical practice.
引用
- Luo H, Chen W, Mai Z, et al. Development and application of Cas13a-based diagnostic assay for Neisseria gonorrhoeae detection and azithromycin resistance identification. J Antimicrob Chemother. 2022. PMID: 34894246. doi:10.1093/jac/dkab447
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。